GSI Group buys NDS Surgical Imaging for $82.5M

Jan. 17, 2013

Bio-optics and biophotonics technologies supplier GSI Group Inc. (NASDAQ: GSIG) has acquired NDS Surgical Imaging (NDS; San Jose, CA), which produces surgical and radiology displays and related peripherals, for $82.5 million in cash.

BioOptics World Editors

Bio-optics and biophotonics technologies supplier GSI Group Inc. (NASDAQ: GSIG; Bedford, MA) has acquired NDS Surgical Imaging (NDS; San Jose, CA), which produces surgical and radiology displays and related peripherals, for $82.5 million in cash. The acquisition is subject to customary closing adjustments.

The acquisition resulted from GSI Group's medical component market strategy, which has been in process for over a year. The combined technology platforms will expand the company's portfolio of highly differentiated photonic technologies supplied to global OEM customers. Also, the medical applications that NDS serves with its products are adjacent to several of GSI's existing medical applications.

NDS was the first to market surgical liquid-crystal displays (LCDs); LED backlights with backlight stabilization in a surgical display; proprietary Color Correction Technology (patent-pending ) and automated LCD calibration technology; 3 and 5 Mpixel medically certified diagnostic LCDs; and ultra-wideband (UWB) wireless technology in the surgical suite. In addition, the company has gained FDA 510(k) approval for LCDs for mammography.

-----

Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Subscribe now to BioOptics World magazine; it's free!

About the Author

BioOptics World Editors

We edited the content of this article, which was contributed by outside sources, to fit our style and substance requirements. (Editor’s Note: BioOptics World has folded as a brand and is now part of Laser Focus World, effective in 2022.)